arrow
Y

Yukihiro Shiraki

Nagoya University
H指数:15
被引数:1,107

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional analysis of adrenocorticotropic-hormone–producing pituitary cells derived from human pluripotent stem cells in murine and primate models of hypopituitarism

从人多能干细胞来源的促肾上腺皮质激素产生垂体细胞在鼠类和灵长类低促性腺激素性腺垂体功能减退症模型中的功能分析

2026-10-020
OAAI
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration

局部而非循环的补体C3通过调控髓系细胞浸润来塑造免疫检查点阻断疗效

2026-07-150
OAAI
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma

按需GLUT3表达增强CAR T细胞在胶质母细胞瘤临床前模型中的代谢适应性和抗肿瘤效果

2026-04-010
PRE
Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation

间皮细胞通过球体形成促进腹水源性卵巢癌细胞的腹膜侵袭和转移

2026-02-060
OA
NOX2-Dependent Phagocyte Signaling Mediates Silica-Induced Murine Lung Injury via Macrophage-Neutrophil Interactions

NOX2依赖的吞噬细胞信号介导二氧化硅诱导的小鼠肺损伤,通过巨噬细胞-中性粒细胞相互作用。

2025-12-170
OAAI
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma

Meflin是进展期骨肉瘤中可通过抗体药物偶联物治疗的靶点。

2025-10-210
OAAI
Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue

间充质基质细胞中超氧化物歧化酶2缺乏诱导交感神经去神经支配并导致棕色脂肪组织功能受损

2025-01-060
OAAI
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
2024-06-074
OA
Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway
2023-11-031
OAAI
Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics (Apr, 10.1038/s41388-022-02288-9, 2022)
2022-05-042
OA
Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics
2022-04-1339
PRE